Christopher Mills
Advisory Group Member & CIO Harwood Capital Management Group
Christopher Mills has 50 years’ investment experience and is Chief Executive Officer and principal shareholder of Harwood Capital Management Limited, the holding company of the Harwood Capital Management Group, since 2011. He founded JO Hambro Capital Management with Jamie Hambro in 1993 acting as Chief Investment Officer and Harwood Wealth with Alan Durant in 2013 until their respective sales in 2011 and 2020. He is CEO of North Atlantic Smaller Companies Investment Trust plc (“NASCIT”) which he has managed since 1982 and Executive Director of Oryx International Growth Fund which he has managed since 1995. NASCIT has delivered a total net asset value per share return of nearly 200x under Mr Mills’ management. He has sat on the Board of over 100 companies during his career including Augean, MJ Gleeson, Ten Entertainment, SureServe, Frenkel Topping and is currently Chairman of EKF Diagnostics and Renalytix Plc.
Robert Naylor
Lead Investment Manager
Robert has 29 years of experience in capital markets, specialising in both the life sciences and investment companies sectors. Robert is currently CEO and Co-Founder of Intuitive Investments Group plc, a London Stock Exchange Specialist Fund Segment investment company providing investors with exposure to fast growing technology and life sciences businesses. Robert is also Non-Executive Director of NIOX Group PLC, a company dedicated to improving asthma diagnosis and management, Renalytix PLC, which is commercialising the only FDA-approved and Medicare reimbursed prognostic test to support early-stage risk assessment for chronic kidney disease, and The PRS REIT plc, a FTSE 250 closed-ended real estate investment company which invests in high-quality, new build, family homes in the private rented sector.
Previously Robert was chairman of Hipgnosis Songs Fund Limited, a FTSE 250 company, which was subject to a recommended cash offer by a newly formed company indirectly wholly owned by investment funds advised by affiliates of Blackstone Inc. Robert was also chairman of Round Hill Music Royalty Fund Limited and oversaw its sale, via a recommended cash offer to a company directly owned by Alchemy Copyrights, LLC, trading as Concord. Earlier in his career Robert held various positions within JP Morgan Asset Management Limited, Panmure Gordon (UK) Limited and Cenkos Securities plc. Robert is a qualified chartered accountant, having started his career with Ernst & Young in 1996.
The information on this website is solely for information purposes and is not intended to be, and should not be construed as, an offer or recommendation to buy and sell investments. If you are in any doubt as to the appropriate course of action, we would recommend that you consult your own independent financial adviser, stockbroker, solicitor, accountant or other professional adviser.
Past performance is no guide to the future. The value of investments and the income from them may go down as well as up and investors may not get back the full amount they originally invested. The information herein has been obtained from sources believed to be reliable but no representation or warranty is given or may be implied that they are accurate or complete.
By entering the Achilles Investment Company Website you agree that you have read, understood and accepted the above.